✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Tolevamer is an investigational drug.
There have been 4 clinical trials for Tolevamer. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2005.
The most common disease conditions in clinical trials are Enterocolitis, Pseudomembranous, Diarrhea, and Enterocolitis. The leading clinical trial sponsors are Genzyme, a Sanofi Company and [disabled in preview].
Recent Clinical Trials for Tolevamer
|A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea||Genzyme, a Sanofi Company||Phase 3|
|A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea||Genzyme, a Sanofi Company||Phase 2|
|A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea||Genzyme, a Sanofi Company||Phase 3|